GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (FRA:BVF) » Definitions » Additional Paid-In Capital

Bausch Health (FRA:BVF) Additional Paid-In Capital : €151 Mil(As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Bausch Health Additional Paid-In Capital?


Bausch Health's quarterly additional paid-in capital increased from Sep. 2023 (€178 Mil) to Dec. 2023 (€196 Mil) but then stayed the same from Dec. 2023 (€196 Mil) to Mar. 2024 (€151 Mil).

Bausch Health's annual additional paid-in capital declined from Dec. 2021 (€409 Mil) to Dec. 2022 (€150 Mil) but then increased from Dec. 2022 (€150 Mil) to Dec. 2023 (€196 Mil).

Bausch Health Additional Paid-In Capital Historical Data

The historical data trend for Bausch Health's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Additional Paid-In Capital Chart

Bausch Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 386.10 373.19 408.87 150.10 196.24

Bausch Health Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 159.71 173.52 178.03 196.24 150.88

Bausch Health Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Bausch Health Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Bausch Health's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch Health (FRA:BVF) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (FRA:BVF) » Definitions » Additional Paid-In Capital
Comparable Companies
XCNQ:GTII TSX:CURA XCNQ:TRUL NEOE:VRNO TSX:CRON TSX:WEED XCNQ:CL TSX:DHT.U NEOE:GLAS.A.U TSX:TSND ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
BHC:USA BVF:Germany BHC:Canada
Address
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Website
https://www.bauschhealth.com
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Bausch Health (FRA:BVF) Headlines

No Headlines